NAMPT-SIRT1 Axis as Master Regulator of SASP-Dependent Complement Amplification

Target: NAMPT, SIRT1 Composite Score: 0.589 Price: $0.59▲0.7% Citation Quality: Pending neurodegeneration Status: promoted

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

🔥 Neuroinflammation 🧠 Neurodegeneration

✓ All Quality Gates Passed

Quality Report Card click to collapse

C+

Composite: 0.589

Top 15% of 628 hypotheses

T4 Speculative

Novel AI-generated, no external validation

Needs 1+ supporting citation to reach Provisional

B+ Mech. Plausibility 15% 0.70 Top 52%

B Evidence Strength 15% 0.60 Top 55%

B+ Novelty 12% 0.75 Top 57%

B Feasibility 12% 0.65 Top 46%

B Impact 12% 0.68 Top 66%

B Druggability 10% 0.60 Top 53%

C+ Safety Profile 8% 0.55 Top 55%

B+ Competition 6% 0.70 Top 51%

A Data Availability 5% 0.80 Top 28%

B Reproducibility 5% 0.65 Top 46%

Evidence

5 supporting | 4 opposing

Citation quality: 0%

Debates

0 sessions

No debates yet

Convergence

0.00 F 30 related hypothesis share this target

From Analysis:

test

test

→ View full analysis & debate transcript

Hypotheses from Same Analysis (1)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Ketone-Based Metabolic Switching to Restore PV Interneuron Function

Score: 0.609 | Target: SIRT3, PVALB

→ View full analysis & all 2 hypotheses

Description

Targeting the NAMPT-NAD+-SIRT1 Axis to Disrupt SASP-Mediated Complement Cascade Amplification. The NAMPT-mediated NAD+ salvage pathway directly controls SIRT1 deacetylase activity, which in turn regulates NFKB1 acetylation status and downstream SASP cytokine production including IL1B. By enhancing NAMPT activity or SIRT1 function, we can suppress the SASP-driven complement C1Q/C3 amplification that mediates synaptic loss.

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

9 citations 9 with PMID Validation: 0% 5 supporting / 4 opposing

✓ For (5)

No supporting evidence

No opposing evidence

(4) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 8CLIN 1GENE 0EPID 0

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
NAMPT-mediated NAD+ salvage pathways are critical …	Supporting	MECH	-	-	-	-	PMID:31553812	-
Ablation of NAMPT in dopaminergic neurons leads to…	Supporting	MECH	-	-	-	-	PMID:39489186	-
P7C3 neuroprotective chemicals function by activat…	Supporting	MECH	-	-	-	-	PMID:25215490	-
TREM2 receptor protects against complement-mediate…	Supporting	MECH	-	-	-	-	PMID:37442133	-
Sirtuin-NAD Activator trial in AD (NCT05040321) us…	Supporting	MECH	-	-	-	-	PMID:NCT05040321	-
SIRT1 has context-dependent roles in neuroinflamma…	Opposing	MECH	-	-	-	-	PMID:27235851	-
NAMPT inhibitors are being explored as anticancer …	Opposing	MECH	-	-	-	-	PMID:27235851	-
SIRT1 activators including resveratrol have failed…	Opposing	CLIN	-	-	-	-	PMID:27235851	-
NAMPT (visfastin) is elevated in metabolic syndrom…	Opposing	MECH	-	-	-	-	PMID:27235851	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 5

NAMPT-mediated NAD+ salvage pathways are critical for neuronal bioenergetics and protection after injury

PMID:31553812

Ablation of NAMPT in dopaminergic neurons leads to neurodegeneration

PMID:39489186

P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage

PMID:25215490

TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1Q

PMID:37442133

Sirtuin-NAD Activator trial in AD (NCT05040321) using MIB-626 provides pathway-specific human validation

PMID:NCT05040321

✗ Opposing Evidence 4

SIRT1 has context-dependent roles in neuroinflammation, with some studies showing that excessive SIRT1 activat…▼

SIRT1 has context-dependent roles in neuroinflammation, with some studies showing that excessive SIRT1 activation can impair protective immune responses

PMID:27235851

NAMPT inhibitors are being explored as anticancer strategies, highlighting the pathway's role in cellular prol…▼

NAMPT inhibitors are being explored as anticancer strategies, highlighting the pathway's role in cellular proliferation

PMID:27235851

SIRT1 activators including resveratrol have failed to demonstrate consistent efficacy in human neurodegenerati…▼

SIRT1 activators including resveratrol have failed to demonstrate consistent efficacy in human neurodegenerative disease trials

PMID:27235851

NAMPT (visfastin) is elevated in metabolic syndrome and inflammation - raising question of whether enhancing a…▼

NAMPT (visfastin) is elevated in metabolic syndrome and inflammation - raising question of whether enhancing already dysregulated pathway is optimal

PMID:27235851

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

No linked debates yet. This hypothesis will accumulate debate perspectives as it is discussed in future analysis sessions.

Price History

7d Trend

↘

Falling

7d Momentum

▲ 0.7%

Volatility

High

0.0747

Events (7d)

⚡ Price Movement Log Recent 3 events

	Event	Price	Change	Source	Time
📄	New Evidence	$0.596	▼ 8.3%	evidence_update	2026-04-16 21:09
📄	New Evidence	$0.650	▲ 10.1%	evidence_update	2026-04-16 21:09
✨	Listed	$0.590		post_process	2026-04-16 21:09